Management of MDR-TB PDF Print E-mail

MDR case management services continued at Kibong’oto National TB hospital with financial support from the GFATM round 6 as planned. The first cohort of the 16 patients admitted in 2009 completed their intensive phase of treatment and were discharged from the hospital for ambulatory treatment at a health facility nearest the patients’ domicile. In order to ensure adequate management of MDR TB in the continuation phase, a system of training district TB coordinators and their respective DOT nurses was set up by the programme in collaboration with University of California San Francisco (UCSF). This included developing district MDR TB training materials followed  by training respective health  workers with financial support from PATH Tanzania. The National MDR-TB operational guidelines were approved by MOHSW in 2010. UCSF supported the programme to train 12 facilitators who in turn trained 38 DTLC 38 and DOT nurses in 3 phases of 12 people each. The participants came from the following districts - Babati (Manyara), Arumeru and Karatu (Arusha), Makete (Iringa), Temeke, Ilala and Kinondoni (Dar es Salaam), Hombolo (Dodoma), Chakechake (Pemba), Mkinga (Tanga), and Newala (Mtwara). 

In 2010, 17 new MDR-TB patients were admitted for treatment at Kibong'oto TB hospital making the total number of patients enrolled since 2009 to 33.  The number of new patients admitted was small because of the ongoing construction within the hospital for a new isolation ward with bed capacity for 20 MDR-TB patients (10 males and 10 females). The wards have self-contained cubicles for 2  patients each thus minimizing nosocomial transmission of MDR-TB strains among the patients and to health care workers.
In November 2010, the first interim analysis was done for the initial 16 MDR-TB admitted at Kibong’oto TB National Hospital. The results were as follows:



At the end of 2010, the MDR TB programme was evaluated by the WHO GLC team and was found to comply with GLC recommendations. As a result, the programme was approved to expand the MDR-TB cohort from the initial 50 patients in the pilot phase to 150 MDR TB patients per year starting 2011.

Last Updated on Sunday, 05 August 2012 14:09